NCT02055716View on ClinicalTrials.gov

Sulforadex in Healthy Human Males MAD

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2014

Study Completion Date

May 31, 2014

Conditions
Prostate Cancer
Interventions
DRUG

Sulforadex

DRUG

alpha-cyclodextrin

Trial Locations (1)

SW17 0RE

Richmond Pharmacology Limited, London

Sponsors

Lead Sponsor

Evgen Pharma
All Listed Sponsors
lead

Evgen Pharma

INDUSTRY

NCT02055716 - Sulforadex in Healthy Human Males MAD | Biotech Hunter | Biotech Hunter